Your browser doesn't support javascript.
loading
Immunogenicity of the Ad26.COV2.S Vaccine for COVID-19.
Stephenson, Kathryn E; Le Gars, Mathieu; Sadoff, Jerald; de Groot, Anne Marit; Heerwegh, Dirk; Truyers, Carla; Atyeo, Caroline; Loos, Carolin; Chandrashekar, Abishek; McMahan, Katherine; Tostanoski, Lisa H; Yu, Jingyou; Gebre, Makda S; Jacob-Dolan, Catherine; Li, Zhenfeng; Patel, Shivani; Peter, Lauren; Liu, Jinyan; Borducchi, Erica N; Nkolola, Joseph P; Souza, Morgana; Tan, Chen Sabrina; Zash, Rebecca; Julg, Boris; Nathavitharana, Ruvandhi R; Shapiro, Roger L; Azim, Ahmed Abdul; Alonso, Carolyn D; Jaegle, Kate; Ansel, Jessica L; Kanjilal, Diane G; Guiney, Caitlin J; Bradshaw, Connor; Tyler, Anna; Makoni, Tatenda; Yanosick, Katherine E; Seaman, Michael S; Lauffenburger, Douglas A; Alter, Galit; Struyf, Frank; Douoguih, Macaya; Van Hoof, Johan; Schuitemaker, Hanneke; Barouch, Dan H.
Afiliación
  • Stephenson KE; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
  • Le Gars M; Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts.
  • Sadoff J; Division of Infectious Diseases, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
  • de Groot AM; Janssen Vaccines & Prevention, Leiden, the Netherlands.
  • Heerwegh D; Janssen Vaccines & Prevention, Leiden, the Netherlands.
  • Truyers C; Janssen Vaccines & Prevention, Leiden, the Netherlands.
  • Atyeo C; Janssen Research & Development, Beerse, Belgium.
  • Loos C; Janssen Research & Development, Beerse, Belgium.
  • Chandrashekar A; Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts.
  • McMahan K; Harvard Medical School, Boston, Massachusetts.
  • Tostanoski LH; Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts.
  • Yu J; Massachusetts Institute of Technology, Cambridge.
  • Gebre MS; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
  • Jacob-Dolan C; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
  • Li Z; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
  • Patel S; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
  • Peter L; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
  • Liu J; Harvard Medical School, Boston, Massachusetts.
  • Borducchi EN; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
  • Nkolola JP; Harvard Medical School, Boston, Massachusetts.
  • Souza M; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
  • Tan CS; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
  • Zash R; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
  • Julg B; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
  • Nathavitharana RR; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
  • Shapiro RL; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
  • Azim AA; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
  • Alonso CD; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
  • Jaegle K; Division of Infectious Diseases, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
  • Ansel JL; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
  • Kanjilal DG; Division of Infectious Diseases, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
  • Guiney CJ; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
  • Bradshaw C; Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts.
  • Tyler A; Division of Infectious Diseases, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
  • Makoni T; Division of Infectious Diseases, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
  • Yanosick KE; Division of Infectious Diseases, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
  • Seaman MS; Division of Infectious Diseases, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
  • Lauffenburger DA; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
  • Alter G; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
  • Struyf F; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
  • Douoguih M; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
  • Van Hoof J; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
  • Schuitemaker H; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
  • Barouch DH; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
JAMA ; 325(15): 1535-1544, 2021 04 20.
Article en En | MEDLINE | ID: mdl-33704352
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Anticuerpos Neutralizantes / Inmunogenicidad Vacunal / Vacunas contra la COVID-19 / COVID-19 / Inmunidad Celular / Anticuerpos Antivirales Tipo de estudio: Clinical_trials Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: JAMA Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Anticuerpos Neutralizantes / Inmunogenicidad Vacunal / Vacunas contra la COVID-19 / COVID-19 / Inmunidad Celular / Anticuerpos Antivirales Tipo de estudio: Clinical_trials Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: JAMA Año: 2021 Tipo del documento: Article